nmrc-m3v-ad-pfca
Vaccineexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2006 (NCT00392015)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Plasmodium falciparumImmunity, active
Plasmodium falciparum immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- nmrc-m3v-ad-pfca
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01843491 | Phase 1 | Jun 1, 2013 | PATH, United States Army, United States Navy |
| NCT00392015 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2006 | Department of Defense, United States Agency for International Development, United States Army, United States Navy |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| United States Army | Government | 2 | 2 | 2 | 2006 |
| United States Navy | Government | 2 | 0 | 2 | 2006 |
| Department of Defense | Government | 1 | 0 | 1 | 2006 |
| PATH | Academic/Hospital | 1 | 0 | 1 | 2013 |
| United States Agency for International Development | Government | 1 | 0 | 1 | 2006 |
5 organizations
Page 1 / 1